WuXi Biologics ("WuXi Bio") (2269.HK), a leading global Contract Research, Development, and Manufacturing Organization (CRDMO), today announced it has been recognized as a 2025 Industry and Regional ...

Asian equities were mostly higher overnight as Mainland China and Hong Kong outperformed and Indonesia and Thailand ...

Deals, pipeline updates and geopolitical issues drove the conversation at the 2025 JP Morgan Healthcare conference.

Wayve, a pioneer in Embodied AI for automotive, is pleased to announce the appointment of Simone Fabris as Vice President of Product and Delivery. Simone's extensive experience in automotive software, ...

The biologics drug substance manufacturing market is witnessing substantial expansion, largely due to the growing prevalence of chronic diseases, which is driving the need for biologics development ...

As we observe World Cancer Day today, let us look at some of the trends in cancer therapeutics expected to improve cancer ...

Since Beijing and Washington imposed tariffs on each other's goods this month, Western media have been closely monitoring whether the trade war will ...

The Hong Kong stock market has moved higher in two straight sessions, advancing almost 500 points or 2.5 percent along the way. The ...

Then on Jan. 6, affiliated company WuXi Biologics said its subsidiary WuXi Vaccines plans to sell its vaccine plant in Ireland to US drugs giant Merck Sharp & Dohme for around USD500 million. WuXi ...